Navigation Links
Quest Diagnostics Named to FORTUNE Magazine's America's Most Admired Companies List
Date:3/5/2008

Only diagnostic testing company in ranking

MADISON, N.J., March 5 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX) today announced that it has been selected by FORTUNE magazine to the 2008 list of America's Most Admired Companies. Quest Diagnostics was ranked third among four companies in the "Health Care" category of "pharmacy and other services." 2008 marks the first year the company has been named to the list.

"Our ranking as one of the most admired companies in America is a tribute to the quality and dedication of our employees and the trust we have earned from patients and physicians as a provider of outstanding diagnostic testing services," said Surya N. Mohapatra, Ph.D., chairman and CEO. "Our ranking as the only diagnostic testing company on the list reinforces our industry leadership and reputation."

FORTUNE's list of America's Most Admired Companies is based on surveys of more than 3,700 executives, directors and securities analysts of companies they admire most in their industry based on eight criteria including Innovation; Quality of Management; Social Responsibility; Use of Corporate Assets; Long Term Investment; People Management; Financial Soundness; and Quality of Products and Services.

The list and related stories appear in the March 17 issue of FORTUNE, on news stands March 10 and currently available online at http://www.fortune.com.

About Quest Diagnostics

Quest Diagnostics is the leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its national network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative new diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at: http://www.questdiagnostics.com.

The statements in this press release that are not historical facts or information may be forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause actual results and outcomes to be materially different. Certain of these risks and uncertainties may include, but are not limited to, competitive environment, changes in government regulations, changing relationships with customers, payers, suppliers and strategic partners and other factors described in the Quest Diagnostics Incorporated 2007 Form 10-K and subsequent SEC filings.


'/>"/>
SOURCE Quest Diagnostics Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. ImmuneRegen Responds to Defense Threat Reduction Agency Request for Information
2. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
3. Quest Diagnostics to Speak at the 2007 UBS Global Life Sciences Conference
4. VioQuest Pharmaceuticals to Present at BIO InvestorForum in San Francisco
5. Quest Diagnostics Joins National ePrescribing Patient Safety Initiative (NEPSI)
6. University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement
7. VioQuest Pharmaceuticals to Present at the Paramount BioSciences Healthcare Conference
8. Sinovac Requests Extension for Annual Shareholders Meeting
9. Maryland Stem Cell Commission Issues Nationwide Request for Applications for New Post-Doctoral Fellowship Grants
10. AmSurg Selects SciQuest Eprocurement Solution to Automate Purchasing of Medical Goods and Services
11. Quest PharmaTech to Receive $3,000,000 to Develop Oncology Products Based on its SonoLight Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2016)... 2016 Part of 5m$ Investment in ... ... Aptuit, LLC today announced that it had successfully completed the ... compounds have increased the Screening Collection to over 400,000. The ... capabilities of the company. This expansion, complemented by new robotics ...
(Date:11/30/2016)... ... November 30, 2016 , ... SSCI, the established leader in small-molecule ... of the latest FDA guidance on pharmaceutical cocrystals as drug substance . ... , The event follows the successful November 15th event that took place ...
(Date:11/30/2016)... , ... November 30, 2016 , ... ... the development of a new orally administered treatment for Alzheimer’s disease (AD), today ... of a Phase 2a clinical trial of T3D-959 in mild to moderate Alzheimer’s ...
(Date:11/30/2016)... ... ... With growth rates averaging more than 30% each year, Random42 has quickly outgrown ... expansion in their new office space. The new office has a fantastic location in ... industries, so Random42 Scientific Communication will fit right in. , Ben Ramsbottom, CEO ...
Breaking Biology Technology:
(Date:6/22/2016)... , June 22, 2016   ... management and verification solutions, has partnered with ... software solutions for Visitor Management, Self-Service Kiosks ... provides products that add functional enhancements to ... provides corporations and venues with an automated ...
(Date:6/16/2016)... 2016 The global ... reach USD 1.83 billion by 2024, according to ... Technological proliferation and increasing demand in commercial buildings, ... drive the market growth.      (Logo: ... development of advanced multimodal techniques for biometric authentication ...
(Date:6/7/2016)... -- Syngrafii Inc. and San Antonio Credit Union (SACU) ... Syngrafii,s patented LongPen™ eSignature "Wet" solution into SACU,s ... in greater convenience for SACU members and operational ... document workflow and compliance requirements. Logo ... Highlights: ...
Breaking Biology News(10 mins):